Collegium Pharmaceutical (COLL) Receivables (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Receivables of $228.8 million for Q1 2026, little changed year-over-year from $228.7 million in Q1 2025, and up 8.25% quarter-over-quarter from $211.3 million in Q4 2025.
Collegium Pharmaceutical (COLL) Receivables (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Receivables history runs 11 years deep, the most recent figure standing at $228.8 million for Q1 2026.
- In Q1 2026, Receivables changed 0.02% year-over-year to $228.8 million; the TTM figure through Mar 2026 stood at $228.8 million (changed 0.02% YoY), while the FY2025 annual figure was $211.3 million, down 7.53% from the prior year.
- Receivables for Q1 2026 stood at $228.8 million, up from $211.3 million in the prior quarter.
- The five-year high for Receivables was $233.9 million in Q3 2025, with the low at $166.3 million in Q1 2022.
- The 5-year median for Receivables is $195.4 million (2022), against an average of $198.9 million.
- The sharpest annual moves came in 2022 and 2023: Receivables jumped 119.21% in 2022, then fell 15.2% in 2023.
- Collegium Pharmaceutical's Receivables stood at $183.1 million in 2022, then dropped by 1.96% to $179.5 million in 2023, then rose by 27.3% to $228.5 million in 2024, then fell by 7.53% to $211.3 million in 2025, then advanced by 8.25% to $228.8 million in 2026.
- Business Quant data shows COLL's Receivables at $228.8 million in Q1 2026, $211.3 million in Q4 2025, and $233.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 304.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 285.10 Mn |
| Mar 31, 2026 | 228.76 Mn |
| Dec 31, 2025 | 211.33 Mn |
| Sep 30, 2025 | 233.95 Mn |
| Jun 30, 2025 | 213.02 Mn |
| Mar 31, 2025 | 228.71 Mn |
| Dec 31, 2024 | 228.54 Mn |
| Sep 30, 2024 | 228.46 Mn |
| Jun 30, 2024 | 183.86 Mn |
| Mar 31, 2024 | 174.69 Mn |
| Dec 31, 2023 | 179.53 Mn |
| Sep 30, 2023 | 181.85 Mn |
| Jun 30, 2023 | 167.48 Mn |
| Mar 31, 2023 | 179.13 Mn |
| Dec 31, 2022 | 183.12 Mn |
| Sep 30, 2022 | 195.40 Mn |
| Jun 30, 2022 | 197.51 Mn |
| Mar 31, 2022 | 166.35 Mn |
| Dec 31, 2021 | 105.84 Mn |
| Sep 30, 2021 | 149.00 Mn |